Oncotelic Therapeutics Inc OTLC:OTCQB

RT Quote | Exchange | USD
Last | 09/17/21 EDT
0.1296quote price arrow down-0.0002 (-0.1541%)
Volume
87,883
52 week range
0.09 - 0.38
Loading...
  • Open0.122
  • Day High0.13
  • Day Low0.122
  • Prev Close0.1298
  • 52 Week High0.38
  • 52 Week High Date01/25/21
  • 52 Week Low0.09
  • 52 Week Low Date08/10/21

Key Stats

  • Market Cap48.13M
  • Shares Out371.35M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-39.72

KEY STATS

  • Open0.122
  • Day High0.13
  • Day Low0.122
  • Prev Close0.1298
  • 52 Week High0.38
  • 52 Week High Date01/25/21
  • 52 Week Low0.09
  • 52 Week Low Date08/10/21
  • Market Cap48.13M
  • Shares Out371.35M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-39.72

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-1.31
  • Fwd P/E (NTM)-2.59
  • EBITDA (MRQ)-10.537M
  • ROE (MRQ)-92.77%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-602.61%
  • Debt To Equity (MRQ)72.82%

EVENTS

  • Earnings Date11/22/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncotelic Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oncotelic Therapeutics, Inc., formerly Mateon Therapeutics, Inc., is an immuno-oncology company. The Company is engaged in development of ribonucleic acid (RNA) therapeutics as well as small molecule drugs against cancer and infectious diseases. The Company’s pipeline includes ArtiVeda/ArtiShield, OT-101, CA4P and Oxi4503. The ArtiVeda/ArtiShield is a derivative from the plant Artemisia. Its immuno-oncology drug candidate, OT-101, is developed for the treatment of solid...
Vuong Trieu Ph.D.
Chief Executive Officer
Amit Shah
Chief Financial Officer
Address
29397 Agoura Road Suite 107
Agoura Hills, CA
91301
United States

Top Peers

SYMBOLLASTCHG%CHG
WINT
Windtree Therapeutics Inc
1.89+0.07+3.85%
CYCC
Cyclacel Pharmaceuticals Inc
5.73-0.05-0.87%
BCDA
BioCardia Inc
3.11+0.23+7.99%
NNVC
NanoViricides Inc
4.02-0.06-1.47%
AZRX
AzurRx BioPharma Inc
3.75-0.09-2.34%